AtaiBeckley Trial Shows Promise for Short-Acting Psychedelic Depression Treatment
Published in JAMA, the phase 2b trial found that a single dose of the psychedelic compound 5-MeO-DMT significantly reduced depressive ...
Published in JAMA, the phase 2b trial found that a single dose of the psychedelic compound 5-MeO-DMT significantly reduced depressive ...
Psychedelics.media delivers trusted news, intelligence, and insights for the global psychedelic medicine industry.
